{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T06:41:09Z","timestamp":1787985669157,"version":"build-2784847793"},"reference-count":146,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T00:00:00Z","timestamp":1625702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Physiol."],"abstract":"<jats:p>The characterization of the cardiac hormone atrial natriuretic peptide (ANP<jats:sub>9<\/jats:sub><jats:sub>9<\/jats:sub><jats:sub>\u2013<\/jats:sub><jats:sub>1<\/jats:sub><jats:sub>26<\/jats:sub>), synthesized and secreted predominantly by atrial myocytes under stimulation by mechanical stretch, has established the heart as an endocrine organ with potent natriuretic, diuretic, and vasodilating actions. Three additional distinct polypeptides resulting from proteolytic cleavage of proANP have been identified in the circulation in humans. The mid-sequence proANP fragment 31\u201367 (also known as proANP<jats:sub>3<\/jats:sub><jats:sub>1<\/jats:sub><jats:sub>\u2013<\/jats:sub><jats:sub>6<\/jats:sub><jats:sub>7<\/jats:sub>) has unique potent and prolonged diuretic and natriuretic properties. In this review, we report the main effects of this circulating hormone in different tissues and organs, and its mechanisms of actions. We further highlight recent evidence on the cardiorenal protective actions of chronic supplementation of synthetic proANP<jats:sub>3<\/jats:sub><jats:sub>1<\/jats:sub><jats:sub>\u2013<\/jats:sub><jats:sub>6<\/jats:sub><jats:sub>7<\/jats:sub> in preclinical models of cardiorenal disease. Finally, we evaluate the use of proANP<jats:sub>3<\/jats:sub><jats:sub>1<\/jats:sub><jats:sub>\u2013<\/jats:sub><jats:sub>6<\/jats:sub><jats:sub>7<\/jats:sub> as a new therapeutic strategy to repair end-organ damage secondary to hypertension, diabetes mellitus, renal diseases, obesity, heart failure, and other morbidities that can lead to impaired cardiac function and structure.<\/jats:p>","DOI":"10.3389\/fphys.2021.691407","type":"journal-article","created":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T08:42:51Z","timestamp":1625733771000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Atrial Natriuretic Peptide31\u201367: A Novel Therapeutic Factor for Cardiovascular Diseases"],"prefix":"10.3389","volume":"12","author":[{"given":"Gustavo Jose Justo","family":"da Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Altara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George W.","family":"Booz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Cataliotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,7,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s10741-017-9619-2","article-title":"Heart failure with preserved ejection fraction: a nephrologist-directed primer.","volume":"22","author":"Afsar","year":"2017","journal-title":"Heart Fail. Rev."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1161\/HYPERTENSIONAHA.120.14704","article-title":"Cardioprotective effects of the novel compound vastiras in a preclinical model of end-organ damage.","volume":"75","author":"Altara","year":"2020","journal-title":"Hypertension"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.peptides.2004.09.023","article-title":"Natriuretic peptide receptor-C signaling and regulation.","volume":"26","author":"Anand-Srivastava","year":"2005","journal-title":"Peptides"},{"key":"B4","first-page":"455","article-title":"Atrial natriuretic factor receptors and signal transduction mechanisms.","volume":"45","author":"Anand-Srivastava","year":"1993","journal-title":"Pharmacol. Rev."},{"key":"B5","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/s1388-9842(01)00161-1","article-title":"Up-regulation of \u2018clearance\u2019 receptors in patients with chronic heart failure: a possible explanation for the resistance to biological effects of cardiac natriuretic hormones.","volume":"3","author":"Andreassi","year":"2001","journal-title":"Eur. J. Heart Fail."},{"key":"B6","doi-asserted-by":"publisher","first-page":"H1529","DOI":"10.1152\/ajpheart.00107.2006","article-title":"Lack of activation of molecular forms of the BNP system in human grade 1 hypertension and relationship to cardiac hypertrophy.","volume":"291","author":"Belluardo","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"R1351","DOI":"10.1152\/ajpregu.1995.269.6.R1351","article-title":"Effect of proANF-(31\u201367) on sodium excretion in conscious monkeys.","volume":"269","author":"Benjamin","year":"1995","journal-title":"Am. J. Physiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"3622","DOI":"10.1210\/jc.2004-1953","article-title":"Lipid mobilization with physiological atrial natriuretic peptide concentrations in humans.","volume":"90","author":"Birkenfeld","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B9","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.2337\/db08-0649","article-title":"Atrial natriuretic peptide induces postprandial lipid oxidation in humans.","volume":"57","author":"Birkenfeld","year":"2008","journal-title":"Diabetes Metab. Res. Rev."},{"key":"B10","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1517\/13543784.13.6.643","article-title":"Recent advances in natriuretic peptides in congestive heart failure.","volume":"13","author":"Boerrigter","year":"2004","journal-title":"Expert Opin. Investig. Drugs"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1172\/JCI59701","article-title":"Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytes.","volume":"122","author":"Bordicchia","year":"2012","journal-title":"J. Clin. Invest."},{"key":"B12","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1152\/physrev.1990.70.3.665","article-title":"Diverse biological actions of atrial natriuretic peptide.","volume":"70","author":"Brenner","year":"1990","journal-title":"Physiol. Rev."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yjmcc.2018.03.005","article-title":"Overexpression of prostaglandin E2 EP4 receptor improves cardiac function after myocardial infarction.","volume":"118","author":"Bryson","year":"2018","journal-title":"J. Mol. Cell Cardiol."},{"key":"B14","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1042\/CS19990194","article-title":"Cardiac peptide stability, aprotinin and room temperature: importance for assessing cardiac function in clinical practice.","volume":"97","author":"Buckley","year":"1999","journal-title":"Clin. Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"F863","DOI":"10.1152\/ajprenal.1984.247.5.F863","article-title":"Effects of synthetic atrial natriuretic factor on renal function and renin release.","volume":"247","author":"Burnett","year":"1984","journal-title":"Am. J. Physiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1126\/science.2935937","article-title":"Atrial natriuretic peptide elevation in congestive heart failure in the human.","volume":"231","author":"Burnett","year":"1986","journal-title":"Science"},{"key":"B17","doi-asserted-by":"publisher","first-page":"4924","DOI":"10.1096\/fj.15-274597","article-title":"Mice lacking prostaglandin E receptor subtype 4 manifest disrupted lipid metabolism attributable to impaired triglyceride clearance.","volume":"29","author":"Cai","year":"2015","journal-title":"FASEB J."},{"key":"B18","doi-asserted-by":"publisher","first-page":"3265","DOI":"10.3390\/ijms20133265","article-title":"Atrial natriuretic peptide: a molecular target of novel therapeutic approaches to cardio-metabolic disease.","volume":"20","author":"Cannone","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1515\/CCLM.2004.212","article-title":"Effect of prolonged physical exercise on urinary proANP1-30 and proANP31-67.","volume":"42","author":"Cappellin","year":"2004","journal-title":"Clin. Chem. Lab. Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.4065\/76.11.1111","article-title":"Circulating natriuretic peptide concentrations in patients with end-stage renal disease: role of brain natriuretic peptide as a biomarker for ventricular remodeling.","volume":"76","author":"Cataliotti","year":"2001","journal-title":"Mayo Clin. Proc."},{"key":"B21","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1210\/en.2015-1693","article-title":"The PGE2 EP3 receptor regulates diet-induced adiposity in male mice.","volume":"157","author":"Ceddia","year":"2016","journal-title":"Endocrinology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"R373","DOI":"10.1152\/ajpregu.1996.271.2.R373","article-title":"Clearance receptors and endopeptidase 24.11: equal role in natriuretic peptide metabolism in conscious sheep.","volume":"271","author":"Charles","year":"1996","journal-title":"Am. J. Physiol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1046\/j.1365-2362.2003.01222.x","article-title":"Mechanisms of renal hyporesponsiveness to ANP in heart failure.","volume":"33","author":"Charloux","year":"2003","journal-title":"Eur. J. Clin. Invest."},{"key":"B24","doi-asserted-by":"publisher","first-page":"H1555","DOI":"10.1152\/ajpheart.2000.278.5.H1555","article-title":"Amelioration with vessel dilator of acute tubular necrosis and renal failure established for 2 days.","volume":"278","author":"Clark","year":"2000","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"H17","DOI":"10.1152\/ajpheart.00684.2005","article-title":"Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications.","volume":"290","author":"Clerico","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1172\/JCI112723","article-title":"Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion.","volume":"78","author":"Cody","year":"1986","journal-title":"J. Clin. Invest."},{"key":"B27","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1056\/NEJM200007273430403","article-title":"Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group.","volume":"343","author":"Colucci","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.biochi.2015.05.017","article-title":"Natriuretic peptide control of energy balance and glucose homeostasis.","volume":"124","author":"Coue","year":"2016","journal-title":"Biochimie"},{"key":"B29","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1126\/science.6419347","article-title":"Purification and sequence analysis of bioactive atrial peptides (atriopeptins).","volume":"223","author":"Currie","year":"1984","journal-title":"Science"},{"key":"B30","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/0024-3205(81)90370-2","article-title":"A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats.","volume":"28","author":"de Bold","year":"1981","journal-title":"Life Sci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/S0140-6736(03)13976-1","article-title":"B-type natriuretic peptide in cardiovascular disease.","volume":"362","author":"de Lemos","year":"2003","journal-title":"Lancet"},{"key":"B32","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/clinchem\/46.6.843","article-title":"Circulating immunoreactive proANP(1-30) and proANP(31-67) in sedentary subjects and athletes.","volume":"46","author":"De Palo","year":"2000","journal-title":"Clin. Chem."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1016\/j.peptides.2011.06.014","article-title":"Expression of C-type natriuretic peptide and its receptor NPR-B in cardiomyocytes.","volume":"32","author":"Del Ry","year":"2011","journal-title":"Peptides"},{"key":"B34","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/S0735-1097(16)31352-3","article-title":"Safety and efficacy of pro ANP 31-67 in cardiorenal syndrome: a first-in-human trial.","volume":"67","author":"Delacroix","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/j.1440-1681.1994.tb02560.x","article-title":"Possible mechanisms involved in the natriuretic response to atrial natriuretic factor (ANF) and proANF 31-67 in the rat.","volume":"21","author":"Dietz","year":"1994","journal-title":"Clin. Exp. Pharmacol. Physiol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1097\/FJC.0000000000000773","article-title":"Myocardial phosphodiesterases and their role in cGMP regulation.","volume":"75","author":"Dunkerly-Eyring","year":"2020","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"B37","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/S0022-2275(20)32003-4","article-title":"Eicosanoids as endogenous regulators of leptin release and lipolysis by mouse adipose tissue in primary culture.","volume":"41","author":"Fain","year":"2000","journal-title":"J. Lipid Res."},{"key":"B38","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/hyp.70.suppl_1.027","article-title":"ProANP 31-67 and renal function in heart failure.","volume":"70","author":"Felder","year":"2017","journal-title":"Hypertension"},{"key":"B39","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s004180050295","article-title":"The endocrine heart and natriuretic peptides: histochemistry, cell biology, and functional aspects of the renal urodilatin system.","volume":"110","author":"Forssmann","year":"1998","journal-title":"Histochem. Cell Biol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"364","DOI":"10.2165\/00007256-198806060-00003","article-title":"Effects of exercise on atrial natriuretic factor. Release mechanisms and implications for fluid homeostasis.","volume":"6","author":"Freund","year":"1988","journal-title":"Sports Med."},{"key":"B41","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jacc.2020.11.044","article-title":"HFpEF is associated with preserved t-tubule integrity but etiology-dependent impairment of diastolic Ca2+ homeostasis.","volume":"77","author":"Frisk","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"B42","doi-asserted-by":"crossref","first-page":"9395","DOI":"10.1016\/S0021-9258(19)76554-5","article-title":"Atrial natriuretic peptide clearance receptor. Complete sequence and functional expression of cDNA clones.","volume":"263","author":"Fuller","year":"1988","journal-title":"J. Biol. Chem."},{"key":"B43","doi-asserted-by":"publisher","first-page":"28230","DOI":"10.1074\/jbc.M113.468603","article-title":"Coordinate functional regulation between microsomal prostaglandin E synthase-1 (mPGES-1) and peroxisome proliferator-activated receptor gamma (PPARgamma) in the conversion of white-to-brown adipocytes.","volume":"288","author":"Garcia-Alonso","year":"2013","journal-title":"J. Biol. Chem."},{"key":"B44","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/s41569-020-0381-0","article-title":"Cardiac natriuretic peptides.","volume":"17","author":"Goetze","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/0196-9781(94)90043-4","article-title":"Molecular forms of circulating atrial natriuretic peptides in human plasma and their metabolites.","volume":"15","author":"Gower","year":"1994","journal-title":"Peptides"},{"key":"B46","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/0006-291x(92)91105-y","article-title":"Processing of atriopeptin prohormone by nonmyocytic atrial cells.","volume":"188","author":"Greenwald","year":"1992","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1172\/JCI115730","article-title":"Atrial natriuretic peptide(31-67) inhibits Na+ transport in rabbit inner medullary collecting duct cells. Role of prostaglandin E2.","volume":"89","author":"Gunning","year":"1992","journal-title":"J. Clin. Invest."},{"key":"B48","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/j.1440-1681.1995.tb01969.x","article-title":"Atrial natriuretic peptide fragments in dogs with experimental heart failure.","volume":"22","author":"Habibullah","year":"1995","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1536\/ihj.16-614","article-title":"Prostaglandin E2 signaling as a target of anti-cardiac fibrosis in heart failure treatment.","volume":"58","author":"Harada","year":"2017","journal-title":"Int. Heart J."},{"key":"B50","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.plefa.2011.01.003","article-title":"Prostaglandin E2 increases cardiac fibroblast proliferation and increases cyclin D expression via EP1 receptor.","volume":"84","author":"Harding","year":"2011","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"B51","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1515\/CCLM.2000.005","article-title":"Enzyme immunoassays for fragments (epitopes) of human proatrial natriuretic peptides.","volume":"38","author":"Hartter","year":"2000","journal-title":"Clin. Chem. Lab. Med"},{"key":"B52","doi-asserted-by":"publisher","first-page":"17442","DOI":"10.1073\/pnas.0508782102","article-title":"Quantitative mass spectral evidence for the absence of circulating brain natriuretic peptide (BNP-32) in severe human heart failure.","volume":"102","author":"Hawkridge","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/0196-9781(92)90065-b","article-title":"C-type natriuretic peptide immunoreactivity in human breast vascular endothelial cells.","volume":"13","author":"Heublein","year":"1992","journal-title":"Peptides"},{"key":"B54","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1093\/cvr\/cvn254","article-title":"Pharmacological activation of the prostaglandin E2 receptor EP4 improves cardiac function after myocardial ischaemia\/reperfusion injury.","volume":"81","author":"Hishikari","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"B55","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1517\/13543784.10.5.935","article-title":"An update on nesiritide for treatment of decompensated heart failure.","volume":"10","author":"Hobbs","year":"2001","journal-title":"Expert Opin. Investig. Drugs"},{"key":"B56","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1161\/01.ATV.0000196747.79349.d1","article-title":"Role of cAMP response element binding protein in cardiovascular remodeling: good, bad, or both?","volume":"26","author":"Ichiki","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13287-020-01633-7","article-title":"Mesenchymal stem cells ameliorate myocardial fibrosis in diabetic cardiomyopathy via the secretion of prostaglandin E2.","volume":"11","author":"Jin","year":"2020","journal-title":"Stem Cell Res. Ther."},{"key":"B58","doi-asserted-by":"publisher","first-page":"6215","DOI":"10.1073\/pnas.93.12.6215","article-title":"The heart communicates with the kidney exclusively through the guanylyl cyclase-A receptor: acute handling of sodium and water in response to volume expansion.","volume":"93","author":"Kishimoto","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B59","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/0014-5793(90)80544-s","article-title":"Cloning and sequence analysis of a cDNA encoding a precursor for rat C-type natriuretic peptide (CNP).","volume":"276","author":"Kojima","year":"1990","journal-title":"FEBS Lett."},{"key":"B60","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/0168-8278(95)80285-1","article-title":"Blunted natriuresis and abnormal systemic hemodynamic responses to C-type and brain natriuretic peptides in rats with cirrhosis.","volume":"22","author":"Komeichi","year":"1995","journal-title":"J. Hepatol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s00395-004-0460-0","article-title":"Molecular physiology of natriuretic peptide signalling.","volume":"99","author":"Kuhn","year":"2004","journal-title":"Basic Res. Cardiol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"727","DOI":"10.3390\/ijms19030727","article-title":"EP4 Agonist L-902,688 Suppresses EndMT and attenuates right ventricular cardiac fibrosis in experimental pulmonary arterial hypertension.","volume":"19","author":"Lai","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"B63","doi-asserted-by":"publisher","first-page":"H33","DOI":"10.1152\/ajpheart.2000.278.1.H33","article-title":"Effects of natriuretic peptides on load and myocardial function in normal and heart failure dogs.","volume":"278","author":"Lainchbury","year":"2000","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.kint.2020.03.027","article-title":"Accumulation of natriuretic peptides is associated with protein energy wasting and activation of browning in white adipose tissue in chronic kidney disease.","volume":"98","author":"Luce","year":"2020","journal-title":"Kidney Int."},{"key":"B65","doi-asserted-by":"publisher","first-page":"H1684","DOI":"10.1152\/ajpheart.1998.274.5.H1684","article-title":"Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure.","volume":"274","author":"Luchner","year":"1998","journal-title":"Am. J. Physiol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1016\/j.jacc.2012.05.049","article-title":"Human hypertension is characterized by a lack of activation of the antihypertensive cardiac hormones ANP and BNP.","volume":"60","author":"Macheret","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1016\/s0735-1097(03)00405-4","article-title":"Bedside B-Type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the Breathing Not Properly Multinational Study.","volume":"41","author":"Maisel","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1097\/01.asn.0000019782.37851.bf","article-title":"Prevention of diabetic nephropathy in rats by prostaglandin E receptor EP1-selective antagonist.","volume":"13","author":"Makino","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s11897-017-0329-9","article-title":"Regulation of cardiomyocyte T-tubular structure: opportunities for therapy.","volume":"14","author":"Manfra","year":"2017","journal-title":"Curr. Heart Fail. Rep."},{"key":"B70","doi-asserted-by":"publisher","first-page":"3184","DOI":"10.1161\/01.cir.94.12.3184","article-title":"Hemodynamic and renal excretory effects of human brain natriuretic peptide infusion in patients with congestive heart failure. A double-blind, placebo-controlled, randomized crossover trial.","volume":"94","author":"Marcus","year":"1996","journal-title":"Circulation"},{"key":"B71","doi-asserted-by":"publisher","first-page":"F1401","DOI":"10.1152\/ajprenal.1990.258.5.F1401","article-title":"Three peptides from the ANF prohormone NH(2)-terminus are natriuretic and\/or kaliuretic.","volume":"258","author":"Martin","year":"1990","journal-title":"Am. J. Physiol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"F649","DOI":"10.1152\/ajprenal.1989.257.4.F649","article-title":"Expression and regulation of ANP receptor subtypes in rat renal glomeruli and papillae.","volume":"257","author":"Martin","year":"1989","journal-title":"Am. J. Physiol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure.","volume":"371","author":"McMurray","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"B74","first-page":"103","article-title":"Urodilatin, a natriuretic peptide with clinical implications.","volume":"3","author":"Meyer","year":"1998","journal-title":"Eur. J. Med. Res."},{"key":"B75","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1097\/MCO.0b013e32836510ed","article-title":"Natriuretic peptides and fat metabolism.","volume":"16","author":"Moro","year":"2013","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1172\/JCI115146","article-title":"Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide.","volume":"87","author":"Mukoyama","year":"1991","journal-title":"J. Clin. Invest."},{"key":"B77","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/s41467-019-08626-y","article-title":"Role of cyclooxygenase-2-mediated prostaglandin E2-prostaglandin E receptor 4 signaling in cardiac reprogramming.","volume":"10","author":"Muraoka","year":"2019","journal-title":"Nat. Commun."},{"key":"B78","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/ki.2012.115","article-title":"The intrinsic prostaglandin E2-EP4 system of the renal tubular epithelium limits the development of tubulointerstitial fibrosis in mice.","volume":"82","author":"Nakagawa","year":"2012","journal-title":"Kidney Int."},{"key":"B79","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1681\/ASN.2015050528","article-title":"PGE2, kidney disease, and cardiovascular risk: beyond hypertension and diabetes.","volume":"27","author":"Nasrallah","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1038\/labinvest.2015.79","article-title":"Prostaglandin E2 increases proximal tubule fluid reabsorption, and modulates cultured proximal tubule cell responses via EP1 and EP4 receptors.","volume":"95","author":"Nasrallah","year":"2015","journal-title":"Lab. Invest."},{"key":"B81","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/labinvest.2017.133","article-title":"PGE2 EP1 receptor inhibits vasopressin-dependent water reabsorption and sodium transport in mouse collecting duct.","volume":"98","author":"Nasrallah","year":"2018","journal-title":"Lab. Invest."},{"key":"B82","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/0002-8703(89)90784-9","article-title":"Prohormone atrial natriuretic peptides 1-30, 31-67, and 99-126 increase in proportion to right ventricular pacing rate.","volume":"117","author":"Ngo","year":"1989","journal-title":"Am. Heart J."},{"key":"B83","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1161\/CIRCHEARTFAILURE.108.790774","article-title":"Detection of endogenous B-type natriuretic peptide at very low concentrations in patients with heart failure.","volume":"1","author":"Niederkofler","year":"2008","journal-title":"Circ. Heart Fail."},{"key":"B84","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1210\/endo-126-4-2225","article-title":"Rat brain natriuretic peptide\u2013tissue distribution and molecular form.","volume":"126","author":"Ogawa","year":"1990","journal-title":"Endocrinology"},{"key":"B85","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3389\/fnmol.2014.00075","article-title":"Guanylyl cyclase\/natriuretic peptide receptor-A signaling antagonizes phosphoinositide hydrolysis, Ca(2+) release, and activation of protein kinase C.","volume":"7","author":"Pandey","year":"2014","journal-title":"Front. Mol. Neurosci."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1324347","DOI":"10.1155\/2016\/1324347","article-title":"Prostaglandin E receptor subtype 4 signaling in the heart: role in ischemia\/reperfusion injury and cardiac hypertrophy.","volume":"2016","author":"Pang","year":"2016","journal-title":"J. Diabetes Res."},{"key":"B87","doi-asserted-by":"publisher","first-page":"F1435","DOI":"10.1152\/ajprenal.00512.2011","article-title":"The PGE(2)-EP4 receptor is necessary for stimulation of the renin-angiotensin-aldosterone system in response to low dietary salt intake in vivo.","volume":"303","author":"Poschke","year":"2012","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"F755","DOI":"10.1152\/ajprenal.2000.279.4.F755","article-title":"EP(1) and EP(4) receptors mediate prostaglandin E(2) actions in the microcirculation of rat kidney.","volume":"279","author":"Purdy","year":"2000","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1161\/HYPERTENSIONAHA.107.102590","article-title":"Reduced cardiac remodeling and function in cardiac-specific EP4 receptor knockout mice with myocardial infarction.","volume":"51","author":"Qian","year":"2008","journal-title":"Hypertension"},{"key":"B90","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.jchf.2019.05.012","article-title":"Differential regulation of ANP and BNP in Acute Decompensated Heart Failure: deficiency of ANP.","volume":"7","author":"Reginauld","year":"2019","journal-title":"JACC Heart Fail."},{"key":"B91","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.jchf.2019.07.003","article-title":"Are some patients with acute heart failure ANP-deficient?","volume":"7","author":"Richards","year":"2019","journal-title":"JACC Heart Fail."},{"key":"B92","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.ejheart.2004.01.003","article-title":"NT-proBNP in heart failure: therapy decisions and monitoring.","volume":"6","author":"Richards","year":"2004","journal-title":"Eur. J. Heart Fail."},{"key":"B93","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1161\/CIRCRESAHA.113.300268","article-title":"Epidemiology of heart failure.","volume":"113","author":"Roger","year":"2013","journal-title":"Circ. Res."},{"key":"B94","doi-asserted-by":"publisher","first-page":"798","DOI":"10.3390\/ijms20040798","article-title":"Molecular implications of natriuretic peptides in the protection from hypertension and target organ damage development.","volume":"20","author":"Rubattu","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B95","doi-asserted-by":"publisher","first-page":"3991","DOI":"10.3390\/ijms20163991","article-title":"Natriuretic peptides in the cardiovascular system: multifaceted roles in physiology, pathology and therapeutics.","volume":"20","author":"Rubattu","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B96","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/s0006-291x(89)80056-7","article-title":"Brain natriuretic peptide is a novel cardiac hormone.","volume":"158","author":"Saito","year":"1989","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B97","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1161\/01.cir.76.1.115","article-title":"Clinical application of atrial natriuretic polypeptide in patients with congestive heart failure: beneficial effects on left ventricular function.","volume":"76","author":"Saito","year":"1987","journal-title":"Circulation"},{"key":"B98","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.1073\/pnas.0611209104","article-title":"Night eating and obesity in the EP3R-deficient mouse.","volume":"104","author":"Sanchez-Alavez","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B99","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1161\/CIRCULATIONAHA.118.035132","article-title":"Relaxing with C-type natriuretic peptide, the guanylyl cyclase B receptor, and pericytes.","volume":"138","author":"Sangaralingham","year":"2018","journal-title":"Circulation"},{"key":"B100","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1093\/eurheartj\/ehz142","article-title":"C-type natriuretic peptide: the heart\u2019s guardian angel.","volume":"41","author":"Sangaralingham","year":"2020","journal-title":"Eur. Heart J."},{"key":"B101","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/0092-8674(89)90513-8","article-title":"The primary structure of a plasma membrane guanylate cyclase demonstrates diversity within this new receptor family.","volume":"58","author":"Schulz","year":"1989","journal-title":"Cell"},{"key":"B102","doi-asserted-by":"publisher","first-page":"F427","DOI":"10.1152\/ajprenal.00072.2004","article-title":"Stimulation of renin release by prostaglandin E2 is mediated by EP2 and EP4 receptors in mouse kidneys.","volume":"287","author":"Schweda","year":"2004","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1002\/ejhf.1531","article-title":"Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the Heart Failure Association of the European Society of Cardiology.","volume":"21","author":"Seferovic","year":"2019","journal-title":"Eur. J. Heart Fail."},{"key":"B104","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1161\/CIRCULATIONAHA.117.033383","article-title":"Endothelial C-type natriuretic peptide acts on pericytes to regulate microcirculatory flow and blood pressure.","volume":"138","author":"Spiranec","year":"2018","journal-title":"Circulation"},{"key":"B105","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/s1071-9164(96)80030-3","article-title":"Renal role of the endogenous natriuretic peptide system in acute congestive heart failure.","volume":"2","author":"Stevens","year":"1996","journal-title":"J. Card. Fail."},{"key":"B106","doi-asserted-by":"publisher","first-page":"H1318","DOI":"10.1152\/ajpheart.1992.263.4.H1318","article-title":"Presence of C-type natriuretic peptide in cultured human endothelial cells and plasma.","volume":"263","author":"Stingo","year":"1992","journal-title":"Am. J. Physiol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/0090-6980(92)90115-a","article-title":"Prostanoid-induced inhibition of lipolysis in rat isolated adipocytes: probable involvement of EP3 receptors.","volume":"43","author":"Strong","year":"1992","journal-title":"Prostaglandins"},{"key":"B108","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/332078a0","article-title":"A new natriuretic peptide in porcine brain.","volume":"332","author":"Sudoh","year":"1988","journal-title":"Nature"},{"key":"B109","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1172\/JCI115933","article-title":"Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-beta. Possible existence of \u201cvascular natriuretic peptide system\u201d.","volume":"90","author":"Suga","year":"1992","journal-title":"J. Clin. Invest."},{"key":"B110","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1172\/JCI113544","article-title":"Synthesis of atrial natriuretic polypeptide in human failing hearts. Evidence for altered processing of atrial natriuretic polypeptide precursor and augmented synthesis of beta-human ANP.","volume":"81","author":"Sugawara","year":"1988","journal-title":"J. Clin. Invest."},{"key":"B111","doi-asserted-by":"publisher","first-page":"11613","DOI":"10.1074\/jbc.R600038200","article-title":"Prostaglandin E receptors.","volume":"282","author":"Sugimoto","year":"2007","journal-title":"J. Biol. Chem."},{"key":"B112","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1194\/jlr.M054817","article-title":"Activation of prostaglandin E2-EP4 signaling reduces chemokine production in adipose tissue.","volume":"56","author":"Tang","year":"2015","journal-title":"J. Lipid Res."},{"key":"B113","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1016\/j.jacc.2009.02.038","article-title":"Natriuretic peptides enhance the production of adiponectin in human adipocytes and in patients with chronic heart failure.","volume":"53","author":"Tsukamoto","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"942","DOI":"10.4161\/psb.4.10.9530","article-title":"Signaling through G protein coupled receptors.","volume":"4","author":"Tuteja","year":"2009","journal-title":"Plant Signal. Behav."},{"key":"B115","first-page":"A13193","article-title":"Prostaglandin E2 receptor EP4 regulates fibrotic changes via intracellular calcium in cardiac fibroblast cells.","volume":"140","author":"Umemura","year":"2019","journal-title":"Circulation"},{"key":"B116","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1111\/obr.12598","article-title":"Natriuretic peptides in the control of lipid metabolism and insulin sensitivity.","volume":"18","author":"Verboven","year":"2017","journal-title":"Obes. Rev."},{"key":"B117","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/j.1440-1681.1995.tb01965.x","article-title":"Atrial natriuretic hormones originating from the N-terminus of the atrial natriuretic factor prohormone.","volume":"22","author":"Vesely","year":"1995","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2174\/187152907780059128","article-title":"Discovery of new cardiovascular hormones for the treatment of congestive heart failure.","volume":"7","author":"Vesely","year":"2007","journal-title":"Cardiovasc. Hematol. Disord. Drug Targets"},{"key":"B119","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0196-9781(90)90070-l","article-title":"Specific binding sites for prohormone atrial natriuretic peptides 1-30, 31-67 and 99-126.","volume":"11","author":"Vesely","year":"1990","journal-title":"Peptides"},{"key":"B120","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1161\/01.cir.98.4.323","article-title":"Vessel dilator enhances sodium and water excretion and has beneficial hemodynamic effects in persons with congestive heart failure.","volume":"98","author":"Vesely","year":"1998","journal-title":"Circulation"},{"key":"B121","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1161\/01.cir.90.3.1129","article-title":"Three peptides from the atrial natriuretic factor prohormone amino terminus lower blood pressure and produce diuresis, natriuresis, and\/or kaliuresis in humans.","volume":"90","author":"Vesely","year":"1994","journal-title":"Circulation"},{"key":"B122","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1016\/s0006-291x(87)80307-8","article-title":"Atrial natriuretic prohormone peptides 1-30, 31-67, and 79-98 vasodilate the aorta.","volume":"148","author":"Vesely","year":"1987","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B123","doi-asserted-by":"publisher","first-page":"230","DOI":"10.3181\/00379727-192-42990","article-title":"Increased release of the N-terminal and C-terminal portions of the prohormone of atrial natriuretic factor during immersion-induced central hypervolemia in normal humans.","volume":"192","author":"Vesely","year":"1989","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"B124","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/s0024-3205(99)00674-8","article-title":"Vessel dilator, long acting natriuretic peptide, and kaliuretic peptide increase circulating prostaglandin E2.","volume":"66","author":"Vesely","year":"2000","journal-title":"Life Sci."},{"key":"B125","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1054\/jcaf.2001.23109","article-title":"Long-acting natriuretic peptide, vessel dilator, and kaliuretic peptide enhance urinary excretion rate of albumin, total protein, and beta(2)-microglobulin in patients with congestive heart failure.","volume":"7","author":"Vesely","year":"2001","journal-title":"J. Card. Fail."},{"key":"B126","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1159\/000173438","article-title":"Specific binding site for pro atrial natriuretic factors 1-30, 31-67, and 99-126 on distal nephrons, proximal tubules, renal cortical and medullary membranes.","volume":"15","author":"Vesely","year":"1992","journal-title":"Ren. Physiol. Biochem."},{"key":"B127","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1097\/00000441-199911000-00008","article-title":"Modulation of renin secretion by atrial natriuretic factor prohormone fragment 31-67.","volume":"318","author":"Villarreal","year":"","journal-title":"Am. J. Med. Sci."},{"key":"B128","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1046\/j.1525-1373.1999.d01-71.x","article-title":"Hemodynamic and renal effects of ProANF31-67 in hypertensive rats.","volume":"221","author":"Villarreal","year":"","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"B129","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1210\/endo.132.4.8462485","article-title":"Detection of C-type natriuretic peptide (CNP) transcript in the rat heart and immune organs.","volume":"132","author":"Vollmar","year":"1993","journal-title":"Endocrinology"},{"key":"B130","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.3390\/ijms20092092","article-title":"ARNi: a novel approach to counteract cardiovascular diseases.","volume":"20","author":"Volpe","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B131","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s40292-015-0112-5","article-title":"Angiotensin II receptor blocker neprilysin inhibitor (ARNI): new avenues in cardiovascular therapy.","volume":"22","author":"Volpe","year":"2015","journal-title":"High Blood Press. Cardiovasc. Prev."},{"key":"B132","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1161\/01.cir.89.5.2232","article-title":"Cardiorenal and neurohumoral effects of endogenous atrial natriuretic peptide in dogs with severe congestive heart failure using a specific antagonist for guanylate cyclase-coupled receptors.","volume":"89","author":"Wada","year":"1994","journal-title":"Circulation"},{"key":"B133","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1536\/ihj.16-200","article-title":"An EP4 receptor agonist inhibits cardiac fibrosis through activation of PKA signaling in hypertrophied heart.","volume":"58","author":"Wang","year":"2017","journal-title":"Int. Heart J."},{"key":"B134","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1161\/01.cir.80.3.438","article-title":"The N-terminus and a 4,000-MW peptide from the midportion of the N-terminus of the atrial natriuretic factor prohormone each circulate in humans and increase in congestive heart failure.","volume":"80","author":"Winters","year":"1989","journal-title":"Circulation"},{"key":"B135","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/s0735-1097(96)00241-0","article-title":"C-type natriuretic peptide-mediated coronary vasodilation: role of the coronary nitric oxide and particulate guanylate cyclase systems.","volume":"28","author":"Wright","year":"1996","journal-title":"J. Am. Coll. Cardiol."},{"key":"B136","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1093\/jmcb\/mjw035","article-title":"Prostaglandin E2 receptor EP3 regulates both adipogenesis and lipolysis in mouse white adipose tissue.","volume":"8","author":"Xu","year":"2016","journal-title":"J. Mol. Cell Biol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"4702","DOI":"10.3892\/mmr.2018.8415","article-title":"Prostaglandin E2 receptor EP4 is involved in the cell growth and invasion of prostate cancer via the cAMPPKA\/PI3KAkt signaling pathway.","volume":"17","author":"Xu","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"B138","doi-asserted-by":"publisher","first-page":"H512","DOI":"10.1152\/ajpheart.00137.2015","article-title":"Pirfenidone exhibits cardioprotective effects by regulating myocardial fibrosis and vascular permeability in pressure-overloaded hearts.","volume":"309","author":"Yamagami","year":"2015","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"B139","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1161\/01.hyp.28.6.988","article-title":"Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy.","volume":"28","author":"Yamamoto","year":"1996","journal-title":"Hypertension"},{"key":"B140","doi-asserted-by":"publisher","first-page":"H2406","DOI":"10.1152\/ajpheart.1997.273.5.H2406","article-title":"Effect of endogenous natriuretic peptide system on ventricular and coronary function in failing heart.","volume":"273","author":"Yamamoto","year":"1997","journal-title":"Am. J. Physiol."},{"key":"B141","doi-asserted-by":"publisher","first-page":"8525","DOI":"10.1073\/pnas.150149097","article-title":"Corin, a transmembrane cardiac serine protease, acts as a pro-atrial natriuretic peptide-converting enzyme.","volume":"97","author":"Yan","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B142","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1124\/pr.112.007195","article-title":"The prostanoid EP4 receptor and its signaling pathway.","volume":"65","author":"Yokoyama","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"B143","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1042\/BJ20090420","article-title":"Prostaglandin EP2 and EP4 receptors modulate expression of the chemokine CCL2 (MCP-1) in response to LPS-induced renal glomerular inflammation.","volume":"422","author":"Zahner","year":"2009","journal-title":"Biochem. J."},{"key":"B144","doi-asserted-by":"publisher","first-page":"F379","DOI":"10.1152\/ajprenal.1986.251.2.F379","article-title":"Atrial peptides inhibit oxygen consumption in kidney medullary collecting duct cells.","volume":"251","author":"Zeidel","year":"1986","journal-title":"Am. J. Physiol."},{"key":"B145","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1038\/s41467-019-09492-4","article-title":"The cyclooxygenase-1\/mPGES-1\/endothelial prostaglandin EP4 receptor pathway constrains myocardial ischemia-reperfusion injury.","volume":"10","author":"Zhu","year":"2019","journal-title":"Nat. Commun."},{"key":"B146","doi-asserted-by":"publisher","first-page":"e002551","DOI":"10.1161\/CIRCHEARTFAILURE.115.002551","article-title":"Plasma biomarkers reflecting profibrotic processes in heart failure with a preserved ejection fraction: data from the prospective comparison of ARNI with ARB on management of heart failure with preserved ejection fraction study.","volume":"9","author":"Zile","year":"2016","journal-title":"Circ. Heart Fail."}],"container-title":["Frontiers in Physiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2021.691407\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T08:43:04Z","timestamp":1625733784000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2021.691407\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,8]]},"references-count":146,"alternative-id":["10.3389\/fphys.2021.691407"],"URL":"https:\/\/doi.org\/10.3389\/fphys.2021.691407","relation":{},"ISSN":["1664-042X"],"issn-type":[{"value":"1664-042X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,8]]},"article-number":"691407"}}